Search - tctmd.com

Displaying 741 - 760 of 804

Sort: Relevancy | Date

News Daily News

Nearly 40% of Diabetic Patients Not Treated With Statins: PINNACLE Registry

Michael O'Riordan

September 13, 2016

News Conference News ESC 2016

Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say

Michael O'Riordan

August 27, 2016

News Daily News

Despite War and Strife, Ischemic Heart Disease Leads Deaths in ‘Arab Spring’

Michael O'Riordan

August 26, 2016

News Daily News

A pesar de la Muerte y las Penurias, la Cardiopatía Isquémica es la Principal Causa de Muerte en la ‘Primavera Árabe’

Michael O'Riordan

August 26, 2016

News Daily News

USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents

Michael O'Riordan

August 09, 2016

News Daily News

Updated ACTION-GWTG Risk Score Aims to Better Predict In-Hospital Mortality After Acute MI

Yael L. Maxwell

August 03, 2016

News Daily News

La Escala de Riesgo Actualizada de ACTION-GWTG Pretende Predecir Mejor la Mortalidad Intrahospitalaria Post-IAM

Yael L. Maxwell

August 03, 2016

News Daily News

The Billions Spent on Healthcare for Sedentary Citizens Warrants Global Response

L.A. McKeown

July 28, 2016

News Daily News

Decline Seen in Readmissions After PCI in the Medicare Population

Todd Neale

July 21, 2016

News Daily News

Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina

Michael O'Riordan

June 30, 2016

News Daily News

FDA 顾问小组小范围建议使用糖尿病药物 empagliflozin 来改善 CVD 死亡率

Michael O'Riordan

June 30, 2016

News Daily News

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Michael O'Riordan

June 30, 2016

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

News Daily News

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

Michael O'Riordan

June 09, 2016

News Daily News

Controversial LIGHT Trial Now Published but Fails to Illuminate CV Risks of Contrave

Michael O'Riordan

March 08, 2016

News Daily News

Optimal Risk Factor Control Translates Into Less Expenditure on Healthcare, Use of Resources

Michael O'Riordan

March 02, 2016

News Daily News

Robert Califf’s FDA Nomination Gets Unanimous Yes from US Senate Committee

Shelley Wood

January 11, 2016

News Daily News

Medicare Part D Has Scant Effect on Outcomes for Acute MI Patients

Yael L. Maxwell

November 04, 2015

News Daily News

Battle Scars: Combat Injury Linked With Cardiovascular Risk

Caitlin E. Cox

November 04, 2015

News Daily News

La Puerta se Cierra para las Dietas Bajas en Grasas en lo que al Manejo del Peso a Largo Plazo se refiere

Todd Neale

November 01, 2015

Advertisement

Nearly 40% of Diabetic Patients Not Treated With Statins: PINNACLE Registry

Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say

Despite War and Strife, Ischemic Heart Disease Leads Deaths in ‘Arab Spring’

A pesar de la Muerte y las Penurias, la Cardiopatía Isquémica es la Principal Causa de Muerte en la ‘Primavera Árabe’

USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents

Updated ACTION-GWTG Risk Score Aims to Better Predict In-Hospital Mortality After Acute MI

La Escala de Riesgo Actualizada de ACTION-GWTG Pretende Predecir Mejor la Mortalidad Intrahospitalaria Post-IAM

The Billions Spent on Healthcare for Sedentary Citizens Warrants Global Response

Decline Seen in Readmissions After PCI in the Medicare Population

Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina

FDA 顾问小组小范围建议使用糖尿病药物 empagliflozin 来改善 CVD 死亡率

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

Controversial LIGHT Trial Now Published but Fails to Illuminate CV Risks of Contrave

Optimal Risk Factor Control Translates Into Less Expenditure on Healthcare, Use of Resources

Robert Califf’s FDA Nomination Gets Unanimous Yes from US Senate Committee

Medicare Part D Has Scant Effect on Outcomes for Acute MI Patients

Battle Scars: Combat Injury Linked With Cardiovascular Risk

La Puerta se Cierra para las Dietas Bajas en Grasas en lo que al Manejo del Peso a Largo Plazo se refiere

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content